Evidence map›Paper›PMID 32929625›Full record

Trial reportWorld journal of urology2021

A prospective, multi-center, open-label, single-arm phase 2b study of autologous adult live cultured buccal epithelial cells (AALBEC) in the treatment of bulbar urethral stricture.

Sanjay B Kulkarni, Hemant Pathak, Sudhir Khanna, Suryakant Choubey

Abstract readClinical Trial, Phase IIMulticenter Study
PubMed Publisher
In one paragraph

Trial report in World journal of urology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Imagining the future: the five "Laws" of endourethroplasty.International urology and nephrology · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Modification of minced buccal mucosal graft endourethral urethroplasty: A pilot study.Indian journal of urology : IJU : journal of the Urological Society of India
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Sanjay B KulkarniKulkarni Endo Surgery Institute and Reconstructive Urology Centre, Pune, India. sanjaybkulkarni@gmail.com.
Hemant PathakTNMC Medical College and B. Y. L. Nair Charitable Hospital, Leelavati Hospital, Mumbai, India.
Sudhir KhannaSir Ganga Ram Hospital, New Delhi, India.
Suryakant ChoubeySt. John's Medical College and Hospital, Bangalore, India.
Kulkarni reconstructive Urology Center · INSir Ganga Ram Hospital · INSt.John's Medical College Hospital · INTopiwala National Medical College & BYL Nair Charitable Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the safety and efficacy of autologous adult live cultured buccal epithelial cells (AALBEC) in treatment and management of bulbar urethral stricture in men.

methodsThis was a prospective, multi-center, open-label, single-arm phase 2b study. A total of 18 male patients with bulbar urethral stricture of at least 1 - 4 cm in length were enrolled in the study. All 16 patients had AALBEC implanted and were included in the safety set. Change in total American Urology Association (AUA) symptom score, urinary flow rates assessed by uroflowmetry and a requirement for surgery after 24 weeks from baseline were determined in patients. Data of treatment efficacy were analyzed.

resultsThe AUA score at baseline was 21 (3.9) that showed a statistically significant reduction starting from week 2 [8 (4.4), p = 0.0001] which sustained until week 24 [2 (1.2), p = 0.0005]. Overall mean total AUA symptom score was reduced by 90.5% after the treatment. Significant reductions from baseline at week-24 were also observed in voiding time (92.5 (47.3) vs. 51.9 (17.4) s, p = 0.0046) and flow time [86.9 (48.2) vs. 47.9 (19.6) s, p = 0.0052]. All patients showed absence of any significant adverse events.

conclusionSignificant improvement was seen in the AUA symptom score and uroflowmetry parameters and no patients required surgery during 24 weeks post-treatment. It can be concluded that AALBEC is a safe and effective treatment for bulbar urethral stricture of 1 - 4 cm length to improve the quality of life and the physiological function of urethra.

Indexed as

AdolescentAdultAgedCells, CulturedEpithelial CellsHumansMaleMiddle AgedMouth MucosaProspective StudiesTransplantation, AutologousUrethral StrictureUrologic Surgical Procedures, MaleYoung AdultAmerican urology association scoreBuccal epithelial cell therapyBulbar urethral strictureEpithelial regenerationUroflowmetry

Identifiers

PMID32929625
OpenAlexW3085364308

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.